American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Mondelez International
MDLZ
|
+$225M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$165M |
| 3 |
Visa
V
|
+$152M |
| 4 |
Booz Allen Hamilton
BAH
|
+$151M |
| 5 |
BorgWarner
BWA
|
+$149M |
Top Sells
| 1 |
PepsiCo
PEP
|
+$273M |
| 2 |
LPNT
LifePoint Health, Inc.
LPNT
|
+$268M |
| 3 |
Meta Platforms (Facebook)
META
|
+$248M |
| 4 |
Gilead Sciences
GILD
|
+$222M |
| 5 |
Johnson & Johnson
JNJ
|
+$214M |
Sector Composition
| 1 | Financials | 16.58% |
| 2 | Technology | 14.76% |
| 3 | Healthcare | 13.64% |
| 4 | Consumer Discretionary | 12.38% |
| 5 | Industrials | 10.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Corcept Therapeutics
CORT
$7.57B
| $3.51M | ﹤0.01% |
250,550
+2,154
| +0.9% | +$30.2K |
|
927
Phibro Animal Health
PAHC
$1.62B
| $3.51M | ﹤0.01% |
81,699
+2,545
| +3% | +$109K |
|
|
FLOW
928
DELISTED
SPX FLOW, Inc.
FLOW
| $3.47M | ﹤0.01% |
66,746
+5,031
| +8% | +$262K |
|
|
PVG
929
DELISTED
PRETIUM RESOURCES INC.
PVG
| $3.46M | ﹤0.01% |
+454,600
| New | +$3.46M |
|
|
VRS
930
DELISTED
Verso Corporation
VRS
| $3.45M | ﹤0.01% |
+102,561
| New | +$3.45M |
|
931
Caleres
CAL
$518M
| $3.42M | ﹤0.01% |
+95,409
| New | +$3.42M |
|
932
Lear
LEA
$5.59B
| $3.37M | ﹤0.01% |
23,250
-10,710
| -32% | -$1.55M |
|
|
UMPQ
933
DELISTED
Umpqua Holdings Corp
UMPQ
| $3.33M | ﹤0.01% |
+160,241
| New | +$3.33M |
|
934
Abercrombie & Fitch
ANF
$4.09B
| $3.33M | ﹤0.01% |
157,543
+1,071
| +0.7% | +$22.6K |
|
935
AerCap
AER
$21.5B
| $3.3M | ﹤0.01% |
57,410
+3,331
| +6% | +$192K |
|
936
Innoviva
INVA
$1.24B
| $3.27M | ﹤0.01% |
214,428
-85,783
| -29% | -$1.31M |
|
937
PTC Therapeutics
PTCT
$4.75B
| $3.26M | ﹤0.01% |
69,384
-22,658
| -25% | -$1.06M |
|
938
iShares TIPS Bond ETF
TIP
$14B
| $3.26M | ﹤0.01% |
29,480
| – | – |
|
|
CDK
939
DELISTED
CDK Global, Inc.
CDK
| $3.25M | ﹤0.01% |
+51,888
| New | +$3.25M |
|
|
FLXN
940
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $3.22M | ﹤0.01% |
172,114
+41,752
| +32% | +$781K |
|
941
Enanta Pharmaceuticals
ENTA
$169M
| $3.21M | ﹤0.01% |
37,606
+5,178
| +16% | +$443K |
|
942
NACCO Industries
NC
$303M
| $3.21M | ﹤0.01% |
98,140
+1,645
| +2% | +$53.9K |
|
943
AppFolio
APPF
$9.93B
| $3.2M | ﹤0.01% |
40,825
+11,558
| +39% | +$906K |
|
|
RESI
944
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $3.19M | ﹤0.01% |
294,030
+2,921
| +1% | +$31.7K |
|
|
ATHN
945
DELISTED
Athenahealth, Inc.
ATHN
| $3.19M | ﹤0.01% |
23,868
+10,431
| +78% | +$1.39M |
|
946
Olin
OLN
$3.03B
| $3.19M | ﹤0.01% |
+124,137
| New | +$3.19M |
|
947
W.P. Carey
WPC
$15.1B
| $3.18M | ﹤0.01% |
50,551
-63,609
| -56% | -$4.01M |
|
948
Lumen
LUMN
$5.99B
| $3.11M | ﹤0.01% |
146,564
+61,268
| +72% | +$1.3M |
|
949
FedEx
FDX
$53.9B
| $3.1M | ﹤0.01% |
12,876
-478,687
| -97% | -$115M |
|
950
Acadia Pharmaceuticals
ACAD
$4.08B
| $3.07M | ﹤0.01% |
147,949
-799
| -0.5% | -$16.6K |
|